Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice

Nigel Irwin, Kerry Hunter, Norma Frizzell, Peter Flatt

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)

Abstract

GLP-1 and GIP are the two key incretin hormones that regulate post-prandial glucose homeostasis. Furthermore, potent enzyme-resistant GIP and GLP-1 receptor agonists such as N-AcGIP and exendin-4 have now been developed. In the present study the effects of stable incretins, exendin-4 and N-AcGIP alone and in combination were examined in mice with high fat feeding induced glucose intolerance. Daily s.c. injections of exendin-4 (50 nmol/kg bw) for 12 days restored glycaemic control and significantly (P
Original languageEnglish
Pages (from-to)70-76
JournalRegulatory Peptides
Volume153
Issue number1-3
DOIs
Publication statusPublished (in print/issue) - Feb 2009

Fingerprint

Dive into the research topics of 'Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice'. Together they form a unique fingerprint.

Cite this